Dr. Dongmei shi, Jining NO.1 peoples’ hospital, China.
Dr. Dongmei Shi π§ͺ is a Professor of Dermatology at Jining No.1 Peopleβs Hospital, specializing in medical mycology π¦ and infection immunology π‘οΈ. She has discovered new fungal species, revealed immune evasion pathways, and developed innovative diagnostic tools π¬. A leader in clinical and translational research, Dr. Shi has led several nationally funded projects π¨π³ and serves on prestigious medical committees π©ββοΈ. Her work significantly advances skin infection treatment and global dermatological science π.
Professional Profile
Scopus profile
π Early Academic Pursuits
Dr. Dongmei Shi earned her doctoral degree in Dermatology and Venereology from the esteemed Fourth Military Medical University. Her academic foundation was built on rigorous training and a commitment to deepening her understanding of skin disorders and infections. From the outset, she demonstrated a keen interest in medical mycology and infection immunology, which laid the groundwork for her future innovations and research contributions.
πΌ Professional Endeavors
Currently serving as a Professor in the Department of Dermatology and the Medical Mycology Laboratory at Jining NO.1 Peopleβs Hospital, Dr. Shi has built an impressive career. With years of clinical experience, she excels in diagnosing and treating a wide range of skin diseases. Her work merges clinical acumen with scientific inquiry, making her a pivotal figure in integrating patient care with research-driven solutions.
π¬ Contributions and Research Focus On ImmunologyΒ
Dr. Shiβs research spans the taxonomy of medical fungi, the pathogenicity of fungal infections, and the immune responses triggered by skin pathogens. She has discovered novel fungal species and immune evasion pathways that pave the way for targeted antifungal drug development. Her innovation extends to clinical technologies, including a rapid fungal detection kit and novel treatment strategies using phototherapy and biologics, improving diagnostic precision and therapeutic outcomes.
π Impact and Influence
Her findings have redefined aspects of fungal taxonomy and infection immunology, directly impacting clinical practices and theoretical knowledge in dermatology. Through her projects funded by the National Natural Science Foundation of China and provincial bodies, she has created platforms for translational research, driving both academic progress and patient care. Her rapid diagnostic tools and immunotherapy strategies are increasingly recognized in the medical community.
π Awards and Honors
Dr. Shiβs leadership and scholarly impact have earned her positions in multiple prestigious organizations. She is a Council Member of the Asia-Pacific Medical Mycology Society, Editorial Board Member of the Chinese Journal of Mycology, and Executive Committee Member in various national dermatological and medical mycology societies. These roles recognize her excellence and her influential voice in shaping dermatological science.
πAcademic Citations
Dr. Shi has published numerous high-quality papers in top-tier dermatological and mycological journals, significantly contributing to the body of literature in her field. Her work on Candidalysin pathways, dendritic cell modulation, and immune response mechanics is frequently cited by peers, reflecting the global relevance and scientific rigor of her research.
π Legacy and Future Contributions
Dr. Dongmei Shi stands as a beacon of innovation in dermatology, bridging research, clinical practice, and technology. Her future work aims to further unravel the complex interplay between fungal pathogens and immune responses, explore personalized immunotherapy, and advance standardization in dermatological diagnostics. As she continues to lead groundbreaking studies and mentor emerging scholars, her legacy is set to inspire generations of medical professionals. π±
πPublications Top Notes
1οΈβ£ Photodynamic therapy combined with palliative resection and secondary healing for periocular basal cell carcinoma with inadequate surgical margins
π©ββοΈ Authors: X. Wang, T. Zhang, T. Li, Y. Song, D. Shi, Dongmei
ποΈ Journal: Photodiagnosis and Photodynamic Therapy
π
Year: 2025
π¬ Type: Article
2οΈβ£ Successful management of recurrent cutaneous granulomas caused by Candida albicans using aminolevulinic acid photodynamic therapy post-surgery: A case report
π©ββοΈ Authors: L. Wang, Y. Feng, S. Wang, Z. Yang, D. Shi, Dongmei
ποΈ Journal: Photodiagnosis and Photodynamic Therapy
π
Year: 2025
π Type: Case Report
3οΈβ£ Immunoglobulin E, the potential accelerator of comorbid psoriasis and atherosclerosis
π©ββοΈ Authors: Y. Wang, D. Li, Z. Yan, D. Shi, Dongmei
π’ Citations: 1
π§ͺ Type: Review
4οΈβ£ Fungal influence on immune cells and inflammatory responses in the tumor microenvironment (Review)
π©ββοΈ Authors: J. Zhang, Y. Feng, D. Li, D. Shi, Dongmei
𧬠Type: Review
5οΈβ£ Decoding the enigmatic role of T-cadherin in tumor angiogenesis
π©ββοΈ Authors: H. Xiong, D. Shi, Dongmei
π§ Type: Review
6οΈβ£ Cardiovascular comorbidities among patients with psoriasis: a national register-based study in China
π©ββοΈ Authors: P. Cui, D. Li, L. Shi, R. Li, D. Shi, Dongmei
ποΈ Journal: Scientific Reports
π
Year: 2024
π’ Citations: 2
π Type: Article
7οΈβ£ Galleria mellonella in vitro model for chromoblastomycosis shows large differences in virulence between isolates
π©ββοΈ Authors: D. Shi, Dongmei, Z. Yang, W. Liao, S. de Hoog, S. Deng
ποΈ Journal: IMA Fungus
π
Year: 2024
π’ Citations: 2
𧫠Type: Article
8οΈβ£ Chinese expert consensus on management of antifungal-resistant dermatophytoses (2024 edition)
π©ββοΈ Authors: G. Liang, X. Li, R. Li, X. Kong, W. Liu
ποΈ Journal: Mycoses
π
Year: 2024
π Type: Consensus Statement